
- GMP
About
Bachem develops and manufactures peptides and oligonucleotides as APIs for pharmaceutical and biotechnology companies. It supports projects from early research and clinical development through commercial GMP supply, with sites in Switzerland, the United States, and the United Kingdom.
Services
Peptide clinical development
Supports peptide API programs from pre-clinical development through Phase I–III trials and market approval preparation, with research-grade and GMP-grade material, process development, and analytical support.
Peptide NCE development
Supports peptide new chemical entities through clinical development with CMC services, process development, and analytical support.
Custom peptide synthesis
Manufactures custom peptides for research needs using non-GMP synthesis, chemical modifications, analytical services, documentation, and aliquoting.
Catalog peptides
Provides catalog peptides for research use.
Peptide commercial manufacturing
Manufactures peptide APIs at commercial GMP scale.
CDMO: development & manufacturing
Oligonucleotide clinical development
Supports oligonucleotide API programs from pre-clinical development through Phase I–III trials and market approval preparation with analytical and process development support.
Oligonucleotide NCE development
Supports oligonucleotide new chemical entities through clinical development with platform-ready analytical methods, process development, and a risk-mitigated CMC framework.
Oligonucleotide commercial manufacturing
Manufactures oligonucleotide APIs at commercial GMP scale.
CDMO: development & manufacturing
Project management
Provides project management support for peptide and oligonucleotide programs.
Quality and regulatory support
Provides quality and regulatory support from early development through marketing authorization, including GMP compliance and regulatory documentation.
Analytical capabilities
Provides GMP analytical services including chromatography, mass spectrometry, sequencing, impurity profiling, stability studies, and reference standards.
Supply and vertical integration
Supports integrated supply from amino acid derivatives and building blocks through large-scale commercial API production.
- What to send
- Non-GMP peptide synthesis: 5 mg to 100 g · Aliquoting starting at 0.5 mg per vial
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · Peptide · Oligonucleotide · Peptides · Oligonucleotides · Custom synthesis · HPLC · Peptide synthesis · LC-MS/MS · Small molecules
- Capacity
- 5 mg to 100 g for non-GMP peptide synthesis · Grams to tons for peptide API manufacturing · 4 GMP sites globally · 1 GMP production site in Switzerland for oligonucleotides · 4 GMP-certified sites across Switzerland and the United States
- Offers
- Stock compounds · Custom synthesis
- Scales
- Milligram · Gram · Kilogram · Ton
- Data supplied
- HPLC
Equipment
- UHPLC
- HPLC
- 2D-UHPLC
- GC
- IC
- TLC
- MCSGP
- ESI-Orbitrap
- ESI-Q-ToF
- MALDI-ToF/ToF
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: analytical capabilities, manufacturing, and clinical/commercial supply
Company
- Type
- CRDMO
- Founded
- 1971
- Team
- 2,500+ team members globally
Locations
- Address
- 3132 Kashiwa Street Torrance, CA 90505 USA
- Sites
- Bubendorf, Switzerland · Vionnaz, Switzerland · Torrance, United States · Vista, United States · St. Helens, United Kingdom · Sisslerfeld, Switzerland
- Serves
- worldwide, Switzerland, United States
Similar labs
Work here? Claim this listing